Hospital Drug Utilization Analysis Tool

Data Collection & Preparation

Required Data Points

To perform a comprehensive drug utilization analysis, the following data elements must be collected from hospital systems:

Drug Identification: Generic name, brand name, National Drug Code (NDC), and Anatomical Therapeutic Chemical (ATC) classification code
Transaction Data: Date of dispensing, quantity dispensed, unit of measure, and department/service line
Financial Data: Unit cost, total cost, reimbursement rates, and payment sources (insurance, patient pay, government programs)
Patient Information: Patient age group, diagnosis codes (ICD-10), and length of stay (for inpatient medications)
Prescriber Data: Prescribing physician specialty and department

Why ATC Classification is Critical: The ATC system provides a standardized hierarchical classification of drugs based on the organ or system on which they act and their therapeutic, pharmacological, and chemical properties. This enables consistent grouping of medications across different databases and facilitates meaningful comparisons of drug utilization patterns.

Data Preparation Process

Clean and standardize drug names to eliminate duplicates and variations in naming conventions
Map all medications to their corresponding ATC codes using the latest WHO classification system
Aggregate transaction data to calculate total quantities and costs for each drug
Validate data integrity by checking for outliers, missing values, and inconsistencies
Create summary datasets grouped by ATC level 1 (anatomical main group) through level 5 (chemical substance)

Analysis & Calculation

Drug Class Cost Calculation

For each ATC drug class, calculate the following metrics:

Total Cost: Sum of (unit cost × quantity dispensed) for all drugs within the class
Cost Percentage: (Class total cost / Overall pharmaceutical expenditure) × 100
Average Unit Cost: Total cost divided by total quantity dispensed
Utilization Volume: Total quantity of drug units dispensed

ABC Analysis Methodology

Perform Pareto analysis to categorize drug classes based on their contribution to total pharmaceutical expenditure:

Class A (High Impact): Top 20% of drug classes contributing to approximately 80% of total costs. These require intensive management and monitoring.
Class B (Medium Impact): Next 30% of drug classes contributing to about 15% of total costs. These require moderate oversight.
Class C (Low Impact): Remaining 50% of drug classes contributing to approximately 5% of total costs. These require routine monitoring.

Strategic Importance: ABC classification enables hospitals to prioritize pharmaceutical management efforts. Class A drugs should be subject to formulary restrictions, prior authorization requirements, and regular clinical review. Class B drugs may benefit from therapeutic substitution programs. Class C drugs can be managed through standard procurement processes.

Utilization Pattern Analysis

Differentiate between cost drivers using a quadrant analysis:

High-Cost, Low-Volume: Specialty medications, biologics, and orphan drugs with high unit costs but limited patient populations
Low-Cost, High-Volume: Common generics like antibiotics, analgesics, and cardiovascular medications with modest unit costs but high dispensing frequency
High-Cost, High-Volume: Critical care medications and newer branded drugs with both high unit costs and frequent use
Low-Cost, Low-Volume: Niche medications with limited clinical application

Reporting & Visualization

Key Reports

Ranked Drug Class Expenditure Report: Sorted list of ATC classes by total cost, including percentage contribution to overall pharmaceutical budget
ABC Classification Summary: Breakdown of drug classes by ABC category with associated costs, volumes, and management recommendations
Utilization Pattern Analysis: Quadrant analysis showing relationship between unit cost and dispensing volume for major drug categories
Trend Analysis Report: Monthly or quarterly cost trends for Class A drug categories to identify seasonal variations or emerging cost drivers

Data Visualizations

Drug Class Cost Distribution

ABC Analysis of Pharmaceutical Expenditure

Sample Analysis Results

ATC Class	Description	Total Cost ($)	% of Total	ABC Class	Utilization Pattern
L01	Antineoplastic agents	2,850,000	28.5%	A	High-Cost, Low-Volume
B05	Blood substitutes and perfusion solutions	1,980,000	19.8%	A	High-Cost, High-Volume
C01	Cardiac therapy	1,250,000	12.5%	A	Low-Cost, High-Volume
A02	Drugs for acid related disorders	890,000	8.9%	B	Low-Cost, High-Volume
J01	Antibacterials for systemic use	720,000	7.2%	B	Low-Cost, High-Volume

Total Pharmaceutical Expenditure

$10,000,000

Annual Hospital Drug Budget

Class A Drugs

42.3%

of total pharmaceutical costs

Class B Drugs

28.9%

of total pharmaceutical costs

Class C Drugs

28.8%

of total pharmaceutical costs